Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Dupilumab efficacy in patients with chronic rhinosinusitis with nasal polyps with and without allergic rhinitis
Anju T. Peters, Martin Wagenmann, Jonathan A. Bernstein, et al.
Allergy and Asthma Proceedings (2023) Vol. 44, Iss. 4, pp. 265-274
Open Access | Times Cited: 17

Showing 17 citing articles:

Effect of Dupilumab in CRSwNP Sinonasal Outcomes from Real Life Studies: A Systematic Review with Meta-analysis
Miguel Rodriguez-Iglesias, Christian Calvo‐Henríquez, Daniel Martín-Jiménez, et al.
Current Allergy and Asthma Reports (2025) Vol. 25, Iss. 1
Open Access | Times Cited: 1
Advances in Biologic Therapies for Allergic Diseases: Current Trends, Emerging Agents, and Future Perspectives
Ewa Alska, Dariusz Łaszczych, Katarzyna Napiórkowska-Baran, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 4, pp. 1079-1079
Open Access | Times Cited: 1
Early clinical improvement of anosmia and sinus nitric oxide in chronic rhinosinusitis with nasal polyps subjects treated with dupilumab
Miguel J. Lanz, C. Eisenlohr, Lianet Herrera Cepeda
Allergy and Asthma Proceedings (2025) Vol. 46, Iss. 2, pp. 105-108
Closed Access | Times Cited: 1
Influence of aeroallergen sensitization and nasal polyposis on mepolizumab response in eosinophilic severe asthma
Fatma Arzu Akkus, Fatih Çölkesen, Tuğba Önalan, et al.
Allergy and Asthma Proceedings (2025) Vol. 46, Iss. 2, pp. 119-125
Closed Access | Times Cited: 1
Brazilian guideline for the use of immunobiologicals in chronic rhinosinusitis with nasal polyps ‒ 2024 update
Wilma Terezinha Anselmo‐Lima, Fabrizio Ricci Romano, Edwin Tamashiro, et al.
Brazilian Journal of Otorhinolaryngology (2024) Vol. 90, Iss. 3, pp. 101394-101394
Open Access | Times Cited: 5
Targeting IL-4 and IL-13 Receptors on Eosinophils in CRSwNP Patients: The Clinical Efficacy of Dupilumab
Giovanna Piazzetta, Nadia Lobello, Emanuela Chiarella, et al.
Journal of Personalized Medicine (2023) Vol. 13, Iss. 9, pp. 1404-1404
Open Access | Times Cited: 12
Efficacy and safety of dupilumab in chronic rhinosinusitis with nasal polyps: A systematic review and meta-analysis
Linger Sim, Norasnieda Md Shukri, Najib Majdi Yaacob, et al.
Expert Review of Clinical Pharmacology (2025)
Closed Access
Efficacy of dupilumab for severe chronic rhinosinusitis with nasal polyps and asthma
Tomoko Tajiri, Motohiko Suzuki, Hirono Nishiyama, et al.
Annals of Allergy Asthma & Immunology (2024) Vol. 133, Iss. 5, pp. 550-558.e2
Closed Access | Times Cited: 3
Editorial: A Successful Translational Story, from Scientific Discoveries to A Breakthrough Therapy for Atopic Dermatitis
Anna De Benedetto
Dermatitis (2024) Vol. 35, Iss. S1, pp. S4-S6
Closed Access | Times Cited: 1
Dupilumab improves outcomes in patients with chronic rhinosinusitis with nasal polyps irrespective of gender: results from the SINUS‐52 trial
Wytske J. Fokkens, Claus Bachert, Claire Hopkins, et al.
Clinical & Translational Immunology (2024) Vol. 13, Iss. 6
Open Access | Times Cited: 1
Dupilumab Improves Clinical Symptoms and Biomarkers in Comorbid Seasonal Timothy Grass Pollen Allergic Rhinitis in Patients With CRSwNP
Caroline Beutner, Stephan Traidl, Martin Wagenmann, et al.
Clinical & Experimental Allergy (2024)
Closed Access | Times Cited: 1
Efficacy of dupilumab on chronic rhinosinusitis with nasal polyps and concomitant asthma in biologic-naive and biologic-pretreated patients
María Sandra Domínguez-Sosa, María Soledad Cabrera-Ramírez, Miriam del Carmen Marrero-Ramos, et al.
Annals of Medicine (2024) Vol. 56, Iss. 1
Open Access | Times Cited: 1
Dupilumab is Efficacious in Young Children with Atopic Dermatitis Regardless of Type 2 Comorbidities
Mark Boguniewicz, Lawrence Sher, Amy S. Paller, et al.
Advances in Therapy (2024) Vol. 41, Iss. 12, pp. 4601-4616
Open Access | Times Cited: 1
Real-World Evaluation of Dupilumab in the Long-Term Management of Eosinophilic Chronic Rhinosinusitis with Nasal Polyps: A Focus on IL-4 and IL-13 Receptor Blockade
Nicola Lombardo, Aurelio D’Ecclesia, Emanuela Chiarella, et al.
Medicina (2024) Vol. 60, Iss. 12, pp. 1996-1996
Open Access | Times Cited: 1
Adherence to guidelines prior to endoscopic sinus surgery in patients with chronic rhinosinusitis and asthma
Lotte Buskbjerg Nøhr, Therese Ovesen, Kasra Zainali-Gill
Danish Medical Journal (2024) Vol. 71, Iss. 2, pp. 1-9
Open Access
Current Medical Management of Chronic Rhinosinusitis in Adults
Moath Abdulrahman Alfaleh
IntechOpen eBooks (2024)
Closed Access
A trajectory of the FDA approval of the first vaccine targeting RSV: A greek tragedy with a happy ending
Joseph A. Bellanti, Russell A. Settipane
Allergy and Asthma Proceedings (2023) Vol. 44, Iss. 4, pp. 217-219
Open Access | Times Cited: 1
Page 1

Scroll to top